Human parvovirus B19 DNA replication induces a DNA damageresponse that is dispensable for cell cycle arrest at phase G₂/M

Medicine and Dentistry

• DNA Synthesis 100%
• DNA Damage Response 100%
• Cell Cycle Arrest 100%
• Parvovirus B19 100%
• Cell Cycle Checkpoint 100%
• G2 Phase 100%
• Infection 30%
• Double Stranded DNA 30%
• Cell Cycle 20%
• Viral Protein 20%
• Progenitor Cell 20%
• Ex Vivo 10%
• Protein P53 10%
• Cell Cycle Progression 10%
• Virus Genome 10%
• Lentivirus 10%
• Virus Replication 10%
• Ataxia Telangiectasia 10%
• Cell Cycle M Phase 10%
• Replication Protein 10%
• Nonstructural Protein 1 10%
• Cell Line 10%
• Transactivation 10%

Keyphrases

• DNA Damage Response 100%
• DNA Replication 100%
• Cell Cycle Arrest 100%
• Parvovirus B19 100%
• B19V 100%
• Single-stranded DNA (ssDNA) 33%
• DNA Genome 33%
• Viral Proteins 22%
• Erythroid Progenitors 22%
• Activation Domain 11%
• Lentivirus 11%
• Phosphorylation 11%
• Related Pathway 11%
• Cell Cycle Progression 11%
• Virus Replication 11%
• P53 Pathway 11%
• Per Se 11%
• Replication Protein A 11%
• Viral Genome 11%
• Hypoxic Condition 11%
• Non-structural Protein 11%
• M Phase 11%
• Rad3 11%
• Ataxia Telangiectasia mutated 11%
• DNA Damage Signaling 11%
• H2AX 11%

Immunology and Microbiology

• Cell Cycle G2 Phase 100%
• Cell Cycle Arrest 100%
• DNA Damage Response 100%
• Human Parvovirus B19 100%
• DNA Synthesis 100%
• Cell Cycle Checkpoint 100%
• Cell Cycle 20%
• Viral Protein 20%
• Cell Line 10%
• Viral Replication 10%
• Lentivirus 10%
• Cell Cycle Progression 10%
• Virus Genome 10%
• Cell Cycle M Phase 10%
• Ataxia Telangiectasia 10%
• P53 10%
• Transactivation 10%